Evaluation of cord blood immunoglobulin E and its association with maternal factors in a group of Iranian newborns.


Journal

Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768

Informations de publication

Date de publication:
08 2019
Historique:
received: 17 11 2018
revised: 25 12 2018
accepted: 14 01 2019
pubmed: 3 4 2019
medline: 13 8 2020
entrez: 3 4 2019
Statut: ppublish

Résumé

Allergic disorders are among the most common diseases around the world especially in children. Many factors contribute to the pathogenesis of atopic disorders, but early events during the pregnancy are very important. The aim of this study was to evaluate the level of cord blood immunoglobulin E (CB-IgE) and its association with maternal in a group of Iranian newborns. In a cross-sectional study, 163 pregnant women randomly selected and information about pregnancy and atopy were taken by questionnaire. Blood samples of mothers and matched cord blood were collected and total serum IgE levels were measured by enzyme-linked immunosorbent assay (ELISA) method. To rolling out the possibility of contamination with maternal blood, total IgA was checked for all the cord blood samples. Sixteen percent of mothers had the history of atopic diseases and the mean IgE level was significantly higher in an atopic than nonatopic mothers (241 vs 102, P < 0.001). About 73.9% of cord blood samples, had high IgE level (>0.9 IU/mL). The level of cord blood IgE (CB-IgE) was not significantly different in male and female newborns (2.14 vs 2.15 IU/mL). There was no significant correlation between maternal factors such as age, pregnancy variables, allergens exposure, smoking, and maternal IgE with cord blood IgE. The results of this study showed that CB-IgE is high in a remarkable number of samples; independent of maternal or fetal factors. Further studies need to evaluate the reasons for the high level of IgE in cord blood in our area.

Identifiants

pubmed: 30937964
doi: 10.1002/jcb.28639
doi:

Substances chimiques

Immunoglobulin E 37341-29-0

Types de publication

Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13658-13663

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Mohammad Fereidouni (M)

Cellular and Molecular Research Center, Medical School, Birjand University of Medical Sciences, Birjand, Iran.

Fateme Arefe Nami (FA)

Asthma, Allergy & Immunology Research Center, Medical School, Birjand University of Medical Sciences, Birjand, Iran.

Elham Serki (E)

Asthma, Allergy & Immunology Research Center, Medical School, Birjand University of Medical Sciences, Birjand, Iran.

Majid Arefi (M)

Institute of Genetics Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH